Pilar Eroles Selected Research

methionine-enkephalin receptor

10/2022	Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?
1/2022	Opioid Receptor Expression in Colorectal Cancer: A Nested Matched Case-Control Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pilar Eroles Research Topics

Disease

40	Breast Neoplasms (Breast Cancer) 03/2022 - 05/2010
25	Neoplasms (Cancer) 10/2022 - 02/2003
6	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2014
5	Triple Negative Breast Neoplasms 10/2019 - 05/2010
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
2	Pathologic Complete Response 01/2021 - 01/2019
2	Kaposi Sarcoma (Kaposi's Sarcoma) 10/2020 - 02/2003
2	Carcinogenesis 10/2020 - 04/2020
1	Disease Progression 08/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2010
1	Sarcoma (Soft Tissue Sarcoma) 03/2007

Drug/Important Bio-Agent (IBA)

12	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2014
11	Trastuzumab (Herceptin)FDA Link 01/2022 - 10/2014
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2016
5	Pharmaceutical PreparationsIBA 10/2020 - 01/2016
4	Phenobarbital (Luminal)FDA Link 09/2021 - 10/2012
4	Biological ProductsIBA 01/2020 - 05/2010
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2012 - 02/2003
3	Estrogen ReceptorsIBA 07/2021 - 12/2012
3	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2019
3	Progesterone Receptors (Progesterone Receptor)IBA 02/2015 - 05/2010
2	methionine-enkephalin receptorIBA 10/2022 - 01/2022
2	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2022 - 01/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 06/2021
2	MTOR InhibitorsIBA 01/2022 - 06/2021
2	Everolimus FDA Link 01/2022 - 06/2021
2	Opioid Receptors (Opioid Receptor)IBA 01/2022 - 01/2022
2	Anesthetics (Anesthetic Agents)IBA 01/2022 - 04/2019
2	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2022
2	Conditioned Culture MediaIBA 12/2021 - 01/2021
2	pertuzumabIBA 12/2021 - 01/2021
2	Docetaxel (Taxotere)FDA Link 12/2021 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 01/2014
2	LigandsIBA 01/2021 - 03/2007
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2020 - 02/2003
2	Taxoids (Taxanes)IBA 10/2019 - 11/2016
2	AntibodiesIBA 01/2019 - 06/2014
2	Messenger RNA (mRNA)IBA 01/2016 - 08/2015
2	Estrogens (Estrogen)FDA Link 02/2015 - 01/2013
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2014 - 05/2010
2	ParaffinIBA 07/2014 - 05/2014
1	methylnaltrexone FDA Link 10/2022
1	Naltrexone (ReVia)FDA LinkGeneric 10/2022
1	Oncogene Proteins (Oncogene Protein)IBA 03/2022
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 12/2021
1	CytokinesIBA 12/2021
1	Transcription Factors (Transcription Factor)IBA 12/2021
1	Fulvestrant (Faslodex)FDA Link 07/2021
1	sapanisertibIBA 06/2021
1	dactolisibIBA 06/2021
1	Neuregulin-1 (Neuregulin 1)IBA 01/2021
1	Aluminum Oxide (Sapphire)IBA 01/2021
1	Celecoxib (Celebrex)FDA Link 10/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2020
1	ProteomeIBA 04/2020
1	AS 35IBA 02/2020
1	Analgesics (Analgesic Drugs)IBA 04/2019
1	human ERBB2 proteinIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Ado-Trastuzumab EmtansineIBA 11/2017
1	Cyclin B1IBA 11/2017
1	taxaneIBA 11/2016
1	Mitogen-Activated Protein Kinase PhosphatasesIBA 11/2016
1	JNK Mitogen-Activated Protein KinasesIBA 11/2016
1	AnthracyclinesIBA 11/2016
1	Metformin (Glucophage)FDA LinkGeneric 08/2016
1	Histones (Histone)IBA 01/2016
1	EnzymesIBA 01/2016
1	Apoptosis Regulatory ProteinsIBA 01/2016
1	MyoglobinIBA 01/2016
1	Therapeutic UsesIBA 02/2015
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 02/2015
1	AntioxidantsIBA 11/2014
1	Oxidants (Oxidizing Agents)IBA 11/2014
1	rucaparibIBA 10/2014
1	olaparibIBA 10/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2014
1	Gefitinib (Iressa)FDA Link 06/2014
1	Formaldehyde (Formol)FDA Link 05/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	A-factor (Streptomyces)IBA 01/2013
1	Aromatase (CYP19)IBA 01/2013
1	ClaudinsIBA 10/2012
1	Platinum Compounds (Compounds, Platinum)IBA 05/2010
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2010
1	AngiopoietinsIBA 03/2007
1	Small Interfering RNA (siRNA)IBA 03/2007

Therapy/Procedure

14	Therapeutics 01/2022 - 05/2010
5	Drug Therapy (Chemotherapy) 01/2020 - 01/2014
2	Neoadjuvant Therapy 01/2021 - 01/2019
1	Analgesia 01/2022
1	Aftercare (After-Treatment) 01/2019
1	Radioimmunotherapy 06/2014